Advances in Digital Pathology and AI in Pathology We are pleased to announce a special issue of the Journal of Clinical and Translational Pathology dedicated to "Advances in Digital Pathology and AI in Pathology." Over the past two decades, digital pathology has undergone significant transformation, with institutions globally integrating digital pathology tools into clinical workflows. The advent of whole slide imaging (WSI), coupled with the development of digital image analysis (DIA) and artificial intelligence (AI) technologies, has opened new avenues for extracting valuable insights from pathology specimens.

Call for Contributions to the GYN Pathology The Journal of Clinical and Translational Pathology (JCTP), the official journal of the Chinese American Pathologists Association (CAPA), invites submissions for its upcoming Special Issue on Gynecologic (GYN) Pathology, with Dr. Pei Hui and Dr. Tong Sun from Yale School of Medicine serving as Guest Editors.

Recent Advances in Pediatric Tumor Pathology Pediatric pathology is a unique subspecialty that involves a vast and complex developmental period ranging from embryos to teenagers. Pediatric pathologists are well-versed in broad aspects of anatomic pathology, molecular diagnostics, and pediatric laboratory medicine. Congenital malformations and inherited disorders, immunodeficiencies and infections, pediatric blood diseases, and tumors are but a few examples of the areas that pediatric pathologists help to diagnose and manage.

Updates of Cytopathology Reporting Systems Cytopathology Reporting Systems provide standardized language for reporting in cytopathology practice. Standardized reporting categories allow effective and consistent communications across different institutions and disciplines, and convey unambiguous and clinically helpful information to our clinicians. Since the establishment of the Bethesda System for Reporting Cervical Cytology, other systems have followed and proved successful.

Recent developments in genitourinary pathology Neoplastic diseases of the genitourinary (GU) system are the most common among all human systems in the United States, accounting for approximately 40% of all male cancers. Prostate, bladder, and kidney cancers rank first, fourth, and sixth, respectively, in terms of cancer incidence. Additionally, testicular cancer is the most common malignant disease in young men in the age group of 15-44 years. It is essential for pathologists and researchers to be updated with new developments in the diagnosis and research of GU cancers.